References
- Aisner J, Jacobs M, Sinabaldi V, Gray W, Eisenberger M. Chemoradiotherapy for the treatment of regionally advanced head and neck cancers. Semin Oncol 1994; 21((5 Suppl 12))35–54
- Umezava H, Suhara Y, Takita T, Okumi Y. New antibiotics, bleomycin A and B. J Antibiot (A) 1966; 19: 200–9
- Kuo M T, Haidle C W. Characterization of chain breakage in DNA induced by bleomycin. Biochem Biophys Acta 1973; 335: 109–13
- Barranco S C, Humphrey R M. The effects of bleomycin on survival and cell progression in Chinese hamster cells in vitro. Cancer Res 1971; 31: 1218–23
- Urade M, Takafumi O, Takashi M, Tokuzo M. Establishment of human squamous carcinoma cell lines highly and minimally sensitive to bleomycin and analysis of factors involved in the sensitivity. Cancer 1992; 69: 2589–97
- Jääskelä-Saari H A, Kairemo K JA, Jekunen A P, et al. Cytotoxicity of bleomycin and external radiation in squamous cell cancer cell lines of head and neck. Cancer Detect Prevent 1996; 20: 279–284
- Shanta V, Krishnamurthi S. Combined bleomycin and radiotherapy in oral cancer. Clin Radiat 1980; 31: 617–21
- Ohnuma T, Holland J F, Masuda H, Waligunda J A, Goldberg G A. Microbiological assay of bleomycin: Inactivation, tissue distribution, and clearance. Cancer 1974; 33: 1230–8
- Kramer W G, Feldman S, Broughton A, Strong J E, Hall S W, Holoye P Y. The pharmacokinetics of bleomycin im man. J Clin Pharmacol 1978; 18: 346–52
- Thakur M L, Mennick M V, Guanasekera S W. Some pharmacological aspects of new radiopharmaceutical 111-In-bleomycin. In Radiopharmaceutical and labeled compounds. IAEA, Vienna 1973; 2: 183–88
- Kairemo K JA, Ramsay H A, Tagesson M, et al. Indium- 111 bleomycin complex for radiochemotherapy of head and neck cancer—dosimetric and biokinetic aspects. Eur J Nucl Med 1996; 23: 631–38
- Grénman R, Burk D, Virolainen E, et al. Clonogenic cell assay for anchorage- dependent squamous carcinoma cell lines using limiting dilution. Int J Cancer 1989; 44: 131–6
- Pekkola-Heino K, Kulmala J, Klemi P, et al. Effects of radiation fractionation on four squamous cell carcinoma lines with dissimilar inherent radiation sensitivity. J Cancer Res Clin Oncol 1991; 117: 597–602
- Aisner J, Hiponia D, Conley B, Jacobs M, Gray W, Belani C P. Combined modalities in the treatment of head and neck cancers. Semin Oncol 1995; 22((3 Suppl 6))28–34
- Smid L, Lesnicar H, Zakotnik B, et al. Radiotherapy, combined with simultaneous chemotherapy with mitomycin C and bleomycin for inoperable head and neck cancer—preliminary report. Int J Radiat Oncol Biol Phys 1995; 32: 769–75
- Sung M W, Chang S O, Choi J H, Kim J Y. Bleomycin sclerotherapy in patients with congenital lymphatic malformation in the head and neck. Am J Otolaryngol 1995; 16: 236–41
- Orford J, Barker A, Thonell S, King P, Murphy J. Bleomycin therapy for cystic hygroma. J Pediatr Surg 1995; 30: 1282–7
- Domenge D, Orlowski S, Luboinski B, et al. Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer 1996; 77: 956–63
- Hou D Y, Maruyama Y. Distribution of 111Inbleomycin complex in small cell lung cancer cells by autoradiography. J Surg Oncol 1992; 51: 236–42